NQO1 and cancer: Since dicoumarol is unlikely to have value as anti-cancer drug owing to its anticoagulant properties, considerable effort has been made to identify related structures with increased potency of inhibition of NQO1, improved specificity and reduced off-target effects85, 86, 87.